GDS International

Publication:

Average Visits per Month:

Next Generation Pharma US

The online business magazine at the heart of international business management news.

Next Generation Pharma US
Next Generation Pharma US Graph of Average visits per month

In Numbers:

Testimonials:

Pharmaceutical Technology

5,800

World Pharmaceuticals

550

NG Pharma US

15,000

Contract Pharma

6,400

There isn’t another publication out there that deals with the most topical issues in pharma as conscientiously and thought provoking as Next Generation Pharma.

Keith Blundy Board Member, Cancer Research Technologye

NGP consistently delivers a standout resource for the industry. Well done to all involved.

Reinhold Gahlmann Managing Director & Head of Drug Development, Biofrontera Bioscience GmbH

©2009 GDS Publishing Ltd. All rights reserved.